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INTRODUCTION
The development of fiber optic technology in the 70’s
had helped to identify the source of upper
gastrointestinal bleeding which was not always caused
by rupture of esophageal varices but also gastric
mucosal lesion.1,2 In 1985, Mc Cormack et al., had
mentioned that morphologic study described vascular
dilatation in mucosa and submucosa without
inflammation. Thus, the gastric lesion was more likely
due to congestion than gastritis.3
Gastric mucosal lesion in patients with portal
hypertension had been identified on agreement in the
Baveno II Consensus in Italy (1996) with the term
portal hypertensive gastropathy. Diagnosis of portal
hypertensive gastropathy (PHG) is based on
combination of endoscopic and histopathologic findings
indicates changes in gastric mucosal conditions
associated with the presence of dilatation and vascular
ectasia of mucosal and submucosal microvascular
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ABSTRACT
The recent advances of endoscopic examination had proven that source of upper gastrointestinal bleeding in liver
cirrhosis is not always caused by esophageal varices rupture but also gastric mucosal lesion. The prevalence of gastric
ulcer in patients with liver cirrhosis is higher than healthy individuals. Imbalance of defensive and aggressive factors
of gastric mucosa may involve in development of portal hypertensive gastropathy (PHG). Several studies reported
hemodynamic changes associated wuth portal hypertension causing decreased mucus layer thickness as one of
mechanism of PHG. Other etiologic factors of PHG were hypoacidity, hypergastrinemia, reduced hexosamin
concentration, mucus metabolic function associated with decreased prostaglandin E2 (PGE2), and increased nitric
oxyde  (NO) which had caused mucus wall thickness changes. Gastric mucus damage induced by portal hypertension
has important role in the pathogenesis of gastric ulcer in liver cirrhosis.
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structure without significant evidence of
inflammation.3-6
Endoscopic description of gastric mucosa in PHG
according to OMED may be classified into mild and
severe grade. Scarlatinna rash, snake skin appearance
or mosaic pattern appearance indicate mild grade, while
cherry red spot and black brown spot of diffuse mucous
bleeding are sign of more severe grade.7
The prevalence of PHG is increased in accordance
with severity of liver disease.8 Mortality rate depends
on Child Pugh classification. Almost 90% patients with
of Child Pugh C liver cirrhosis will die in 12 months.7
Initial bleeding had high mortality rate of 50%, while
recurrent bleeding had 70% in one year period.9 Sarin et
al., reported the incidence of PHG was varied from 4%
to 98% with prevalence of 53% portal hypertension due
to liver cirrhosis.5 Incidence of PHG had been reported
to worsen after variceal eradication by sclerotheraphy
with higher risk of bleeding. Variceal ligation had lower
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risk of bleeding possibly because ligation does not cause
total variceal obliteration and allow redistribution of blood
in gastric and esophageal mucosa.5,8 On the other hand,
Viegeneri reported no correlation between endoscopic
findings, Child-Pugh score and esophageal varices
grading (Beppu score).10 Cales et al., also found no
significant correlation between the incidence of
gastropathy and Child-Pugh score.11
The exact mechanism and pathogenesis of PHG
remains unclear, but portal hypertension might be caused
by vascular resistance, increased pressure in portal
system and many humoral factors involved.1,12 How the
blood flows in the mucosa of PHG is still controversial.
Several researcher found association between size of
varices with hepatic portal venous pressure gradient and
the incidence of PHG.11 Most of studies had reported
decreased blood flow gastric mucosa due to congestion,
while Iwao et al stated that PHG was caused by
increased portal pressure and reduced hepatic blood
flow.11 Study by Linn et al., indicated that portal
pressure was the only cause of PHG. The controversies
Figure 1. Pathogenesis of PHG Theory 1,6,11,15,17
continued on blood flow in gastric mucosa. Some
reported it was increased in PHG while the others
reported the other way around. Experimental study by
Imanishi using rat as animal model showed that
hemodynamic changes due to PHG may cause thinning
of mucus layer in gastric mucosa.6
Gastric acid secretion activity decreased because
gastric mucosal barrier is damaged, thus it causes local
hemodynamic changes resulting active and passive
congestion and hyperemic gastric mucosa.13 Humoral
factors have role in PHG by decreasing mucosa
metabolic function, decreased response to pentagastrin,
decreased mucosa glycoprotein, decreased
prostaglandin E2 (PGE2) level and increased nitrite
oxide (NO) synthesis. All these will make the luminal
gastric acid decreased and cause reduced response of
defensive factors to intraluminal stimulation of inciting
factors such as H+ back-diffusion, bile acid and non
steroidal anti-inflammatory drug (NSAID). All may
cause electrical potential changes in the mucosa and
increased fragility of gastric mucosa to injury.14-17
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Defense mecanism of gastroduodenal mucosa
In normal condition, there is balance between
aggressive and defensive factors. When the aggressive
factors reach beyond the defensive factors, disease will
occur.18 The well-known theory called balance theory
refers to balancing between aggressive and defensive
factors. The aggressive factors are gastric acid, pepsin,
bile reflux, drugs (corticosteroid; NSAID), food and drinks
(acid; alcohol), smoke (nicotine) and infection
(Helicobacter pylori). The defensive factors mucus,
bicarbonate, prostaglandin, surface epithelial layer,
mucus blood circulation (micro circulation and motility)
and hexoxamin.18,19 The defensive factors have role in
defense mechanism or cytoprotection. It refers to
the ability of epithelial mucosal cells to defense from
any insult that can damage the integrity of mucosa.
Mucosal integrity consists of 3 components; pre-epithel,
epithel and subepithel.18-20 The pre-epithelial component
has the protective role. The mucus functions as barrier
to support the neutralization of hydrogen ion by
bicarbonate secretion to maintain normal pH gradient on
mucosal epithelial layer in order to prevent injury from
insulting agents.18-21
Gastric mucosa and duodenum are layered by
mucus barrier of pH and bicarbonate, while it also
covered by thick mucus gel, connected by gelatinous
layer. Cecillia et al., found that mucus thickness was
ranging from 50 mm to 450 mm,21 while others found it
thinner between 73 mm and 145 mm. Mucus contains
95% of water and 5% of glycoprotein which keeps on
secreted dynamically by mucous glands. It consists of
several layers and can protect from acid and pepsin.
Mucus function not only to protect before the lesion is
formed but it can help healing process and work as
lubricants to prevent mechanical damage during
digestive process.18-21
Gastric glands have several layers. The upper layer
called submucosa layer, muscularis layer, mucus
secreting cells and mucus layer and finally
the lumen.20-22 About 75% gastric glands found
in corpus in parietal mucosa (oxyntic) and are in charge
in acid secretions. Parietal mucosa consists of parietal
lining cells, chief cell (zymogen), mucus neck cell and
endocrine cell.22 Lining epithel in gastric lumen are thick
folds called rugae. The thickness of the epithelial layer
and rugae are different for each part of gaster. Gastric
surface epithelial cells which invaginated microscopically
are called gastric pit. Each epithelial cell contains mucus
cell and endocrine cell. Every 1-3 days the epithelial cells
migrate to upper part of folveulus to prevent injury
induced by acid, pepsin, food and other pathogenic agents
through mucus and bicarbonate secretion forming
protective secretion layer.21,22
About 50% of endocrine cells are G-cells which
placed in antrum, other 30% secrete serotonin and 15%
produce somatostatin which are distributed in the antral
mucosa and oxyntic. G-cells not only produce gastrin
but also contain adrenocorticotropic hormone (ACTH).
Gastrin is main growth factor for oxyntic mucosa and
directly stimulates cell proliferation. In continuous
hypergastrinemia, both parietal cells and mucus cells
increase the number of G-cell associated to increased
acid secretion.21
Gaster in liver cirrhosis
Sergio Vigneri et al., studied three subject groups of
patients with cirrhosis and portal hypertension,
cirrhosis without portal hypertension and control group.10
It was found that the most frequent endoscopic findings
were snake skin (75%), scarlattina rash (70%) and
petechiae (60%) in patients with cirrhosis and portal
hypertension and no characteristic of inflammation in
gastric mucosa. Gastric mucosa in patients with
cirrhosis indicated the association with portal
hypertension.13 Reference data showed that
vasculopathy is characteristic for congestive gastropathy
in patients with portal hypertension. Quintero et al., found
that ectasia description in capillary area in antral
mucosa with red spot in cirrhotic patients is associated
with hypergastrinemic condition.14 A study by Lam was
supported this finding. Gastrin level was signicant higher
than in control subjects. The presence of mucosal
abnormalities can be observed by endoscopy had showed
that there were 2 conditions of portal hypertension:
gastropathy and varices. PHG criteria had been used
according to Mc Cormack  et al.,  also NIEC and OMED,
while the severity of varices is determined by the level
of variceal protrusion into lumen of esophagus.3,7,23
The evaluation of gastric mucosa by endoscopy
includes that PHG must be seen in proximal of gaster
(fundus/corpus) with or without disorders in the antrum.
If the abnormalities were only found in the antrum, it is
not considered PHG.
Gastric mucosa is constantly exposed to dangerous
substances such as hydrochloric acid, pepsin,
lysolecithin, bile acid and exogenous factors like alcohol,
NSAID, etc. To protect against all those agents, gastric
mucosa has defense mechanism. Tanoe et al., found that
defense mechanism in patients with portal
hypertension was reduced compare to control.12 On the
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with mucus gel thickness in tetrachloride induced liver
cirrhotic mice.17 Pentagastrin stimulated gastric acid
secretion less in PHG than in control group. These
finding indicated that portal hypertension might be
responsible in reducing acid secretion in PHG.15
Defensive factor in liver cirrhosis
1. Gastric mucosal modulator
The main modulators of gastric mucosa are
prostaglandin and NO. The gastric mucosa might be
susceptible to injury caused by suppressed
endogenous prostaglandin (PGE) production.
Gastric PGE2 is reduced in cirrhosis, thus decreased
prostaglandin level on gastric mucosa is associated
with portal hypertension. Research data showed
suppressed generation of gastric prostaglandin was
one of mucosal defense mechanism in portal
hypertension.15 However, little known about NO
production in portal hypertension. This might be due
to difficulties in measuring NO concentration directly.
Gastric constitutive NO mRNA was found increased
in mice with portal hypertension. Ohta et al., found
that normalization of NO synthesis activity was
associated with less mucosal injury. It was assumed
that excessive inducible NO might be cytotoxic and
had role in increasing gastric mucosa susceptibility
in portal hypertension.15
2. Gastric mucosal blood flow
Gastric mucosal blood flow has important role in
defense mechanism because it is responsible to
allow back diffusion in order to eliminate toxin and
inciting agent of injury.12,17 About 90% gastric blood
in human flows through the mucosa. Hemodynamic
changes in animal model may induce portal
hypertension.6 hemodynamic and morphologic
studies had showed ischemic condition in gastric
mucosa was in accordance with increased
submucosal blood flow. Soto found congestion and
blood stasis in mucosa had reduced oxygen
perfusion. Gastric mucosal congestion and hypoxia
had caused the mucosa susceptible to aggressive
factors.17 Change in mucosal blood flow in patients
with PHG is still controversial. Iwao et al., reported
decreased perfusion. These controversies emerged
caused by lack of adequate methods for measuring
blood flow in human. Any changes occur in gastric
mucosal blood flow in portal hypertension,
the presence of hyperemic mucosal appearance
indicates damaged mucosal resistance caused by
dangerous agents.28
other hand, Kitano et al., found the imbalance of
aggressive and defensive factors in patients with
cirrhosis compare to non cirrhotic patients.15
Aggressive factors e.g. Helicobacter pylori infection,
acid and pepsin only had little influence in the
pathogenesis of gastric ulcers in cirrhosis. Portal
hypertension tended to decrease incidence of
Helicobacter pylori infection and reduced gastric acid
secretion but the prevalence of gastric ulcers was
increased. Toyonaga et al., reported prevalence of
gastric ulcer (20%), gastric     erosion (44%), while Chen
et al., reported gastric ulcers (20.8%) in liver cirrhosis.4
Based on these findings, it was assumed that portal
hypertension as one etiologic cause of increased
prevalence of gastric lesion in  patients with cirrhosis.
Aggressive factors in liver cirrhosis
1. Helicobacter pylori infection
Mc Cormack et al., found the prevalence of
Helicobacter pylori colonization was 26%
compare to 38% in control group.3 In addition,
Helicobacter pylori was found to decrease the
severity of PHG. It was assumed that gastric
mucosa in patient with PHG did not provide suitable
environment for Helicobacter pylori colonization.16
On the other hand, Kitano et al., did not found
correlation between Helicobacter pylori
prevalence and severity of PHG or esophageal
varices.15
2. Gastric acid secretion
Gastric acid secretion in liver cirrhosis is generally
less than usual or normal at least.24 Most studies
only measured basal or stimulated acid secretion.
Only one study had evaluated gastric acidity for 24
hours in liver cirrhosis.25 Hypoacidity was found
more in patients with liver cirrhosis than in control
group. The mechanism of reduced acid secretion in
liver cirrhosis remains unclear. Gaur et al., did not
find correlation between acid secretion and
hepatocelullar dysfunction severity in liver cirrhosis.
Conversely, Ferraz & Wallace found epithelial
acidification rate in response to acid load correlated
Table 1. Manual Appearance of PHG 2,3,6  
Mild PHG Severe PHG 
Scarlatina type rash 
Mosaic pattern, snake skin 
Superficil reddening 
Red spots 
Diffuse hemorrhagic gastritis 
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3. Gastric mucus in portal hypertension
There has not been study to evaluate the role of
mucus in PHG and its association with mucus
thickness in human. Imanishi et al., had done the study
on mice and concluded that pathogenesis of bleeding
in PHG might be associated with decreased mucus
thickness and condition.6 Gastric mucus thickness was
also found to be reduced in cirrhotic mice like shown
by in vivo study microscopically. It was assumed to
be related with potential differences in cellular
homeostasis.17 Defensive factors capacity in response
to intra luminal stimulation is decreased due to
induction by aggressive factors make the mucosa
more susceptible and prone to bleeding.1 Mucus layer
which covers gastric mucosa is secreted by mucus
secreting cells induced by acid, pepsin and luminal
fluid flow. Thickness of mucus layer is dynamic and
depends on balance of mucin production by mucus
secreting cell in the apical part of the surface. In PHG
there are hemodynamic changes in gaster that can
reduce mucus production and alter the mucus
structure.26-28
Visualization of mucus gel layer histologically is
difficult, that is why preservation technique and analysis
were developed by various methods. Mucus thickness
of gastric mucosa layer in mice was varied from 73 mm
to 145 mm, but other study using frozen section found
the mucus thickness between 23.9 mm and 53.7 mm.
This difference might be due to different study methods
and technical procedure.6,21,22
 Gastric mucus is important component of gastric
defense mechanism. Basic components of gastric
mucus are mucus gel layer and mucinous contain.
Mucus production has important role in coping with mild
irritation which can damage sitoprotective adaptation of
gastric mucosa in PHG such as reduced concentration
of hexosamin14 and decreased mucus production.28 Iwao
et al., found that PHG had reduced production of antral
gastric mucus. Gastric mucosal hexosamin level may be
used as quantitative parameter of mucus generation.
Hexosamin is known to be gastric mucosal defensive
factor.28 Kaynema et al., reported that portal
hypertension affect mucus thickness layer.19 Reduced
hexosamin concentration in gastric mucus in
constrictive portal vein indicated increasing ulcer index.
The antral mucus thickness was shown to decrease in
early phase compare to those in corpus.19 Tanoe et al.,
found significant lower concentration of hexosamin in
mice with portal hypertension than by pass surgery
control group.12 The administration of teprenone had
significantly increased hexosamin concentration of
gastric mucus in by pass surgery and portal
hypertensive mice.
Imanishi et al., pressumed that portal hypertension
affect the mucus surface thickness. The study methods
included make portal hypertension condition by portal
vein ligation to obtain pre hepatic portal hypertension and
cirrhotic condition in mice.16 It was found that gastric
corpus and antral mucus was significantly reduced in
both groups of cirrhotic and pre hepatic portal
hypertensive mice compare to control group. This
finding indicated that antrum was susceptible to change
during acute phase and corpus was affected by chronic
phase.
In gastric ulcer, there are changes in structural
formation of gel polymeric of mucus glycoprotein that
made it fragile to cover the mucosa. On the other hand,
the changes in portal hypertension include hemodynamic
changes might be responsible in decreased production
and structural changes of mucus.6,15
Erosion in gastric mucosal lesion in patients with
portal hypertension makes the gastric mucosa more
susceptible to injury. The gastric acid secretion and
aggressive factors do not have important role in this
condition. On the other hand, gastric mucosal circulation
associated with reduced oxygenation and perfusion which
are essential in defense mechanism is decreased in
PHG.6,28,29 Study of gastric mucus weakness in mice
measured by potential changes revealed that gastric
mucus showed decreased potential changes during rest
condition and more reduced in ethanol and aspirin
exposure1,6 In addition, gastric mucosa in cirrhotic mice
cannot maintain neutral intracellular pH during acid
administration and viability of gastric mucosal epithelial
decrease significantly.
Finally, reduced mucus layer is caused by various
factors such as changes in mucosal blood flow,
oxygenation, cholinergic control or PG level. All these
factors make high portal pressure and alter the mucosal
hemodynamic and affect the mucus secretion by mucus
secreting cells or changes in mucus viscosity.6,28 Aside
from that, It had been reported that there were decreased
in mucosal metabolism in PHG which manifested in
decreased response to pentagastrin, decreased mucus
glycoprotein, decreased PGE2 and increased nitrite
oxide synthesis. These factors had caused gastric
mucosal acid reduced, induced potential changes in
mucosa electrically and finally, increased susceptibility
of gastric mucosa
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CONCLUSION 
Imbalance of defensive and aggressive factors of  
gastric mucosa may involve in development of PHG.  
Hemodynamic changes, hypoacidity, decreased mucosal  
metabolic function and decreased hexosamin  
concentration known to be associated with portal  
hypertensions wich result in decreased mucus thickness  
as one of the mechanism of PHG. Gastric mucus  
damage induced by portal hypertension has important  
role in the pathogenesis of gastric ulcer in liver cirrhosis. 
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